Sfoglia per Rivista JAMA ONCOLOGY
Interstitial Lung Disease Induced by Anti-ERBB2 Antibody-Drug Conjugates: A Review
2021 P. Tarantino, S. Modi, S.M. Tolaney, J. Cortes, E.P. Hamilton, S.-. Kim, M. Toi, F. Andre, G. Curigliano
Magnetic Resonance Imaging-Based Prediction of Prostate Cancer Risk
2018 G. Bianchi, M.C. Sighinolfi, B. Rocco
Maintenance Therapies for Hodgkin and Non-Hodgkin Lymphomas after Autologous Transplantation: A Consensus Project of ASBMT, CIBMTR, and the Lymphoma Working Party of EBMT
2019 A.S. Kanate, A. Kumar, P. Dreger, M. Dreyling, S. Le Gouill, P. Corradini, C. Bredeson, T.S. Fenske, S.M. Smith, A. Sureda, A. Moskowitz, J.W. Friedberg, D.J. Inwards, A.F. Herrera, M.A. Kharfan-Dabaja, N. Reddy, S. Montoto, S.P. Robinson, S.A. Abutalib, C. Gisselbre, J. Vose, A. Gopal, M. Shadman, M. Perales, P. Carpenter, B.N. Savani, M. Hamadani
Maintenance Therapy with Panitumumab Alone vs Panitumumab Plus Fluorouracil-Leucovorin in Patients with RAS Wild-Type Metastatic Colorectal Cancer: A Phase 2 Randomized Clinical Trial
2019 F. Pietrantonio, F. Morano, S. Corallo, R. Miceli, S. Lonardi, A. Raimondi, C. Cremolini, L. Rimassa, F. Bergamo, A. Sartore-Bianchi, M. Tampellini, P. Racca, M. Clavarezza, R. Berenato, M. Caporale, M. Antista, M. Niger, V. Smiroldo, R. Murialdo, A. Zaniboni, V. Adamo, G. Tomasello, M. Giordano, F. Petrelli, R. Longarini, S. Cinieri, A. Falcone, V. Zagonel, M. Di Bartolomeo, F. de Braud
Molecular markers beyond microsatellite instability for assessing prognosis in early-stage colorectal cancer: What happens at relapse?
2017 A. Sartore-Bianchi
Moving from Cancer Burden to Cancer Genomics for Smoldering Myeloma : a Review
2019 F. Maura, N. Bolli, E.H. Rustad, M. Hultcrantz, N. Munshi, O. Landgren
Rechallenge for Patients with RAS and BRAF Wild-Type Metastatic Colorectal Cancer with Acquired Resistance to First-line Cetuximab and Irinotecan: A Phase 2 Single-Arm Clinical Trial
2019 C. Cremolini, D. Rossini, E. Dell'Aquila, S. Lonardi, E. Conca, M. Del Re, A. Busico, F. Pietrantonio, R. Danesi, G. Aprile, E. Tamburini, C. Barone, G. Masi, F. Pantano, F. Pucci, D.C. Corsi, N. Pella, F. Bergamo, E. Rofi, C. Barbara, A. Falcone, D. Santini
Safety, Tolerability, and Management of Toxic Effects of Phosphatidylinositol 3-Kinase Inhibitor Treatment in Patients with Cancer: A Review
2019 A. Esposito, G. Viale, G. Curigliano
Safety, Tolerability, and Potential Clinical Activity of a Glucocorticoid-Induced TNF Receptor-Related Protein Agonist Alone or in Combination with Nivolumab for Patients with Advanced Solid Tumors : A Phase 1/2a Dose-Escalation and Cohort-Expansion Clinical Trial
2020 K.M. Heinhuis, M. Carlino, M. Joerger, M. Di Nicola, T. Meniawy, S. Rottey, V. Moreno, A. Gazzah, J.-. Delord, L. Paz-Ares, C. Britschgi, R.J. Schilder, K. O'Byrne, G. Curigliano, E. Romano, P. Patah, R. Wang, Y. Liu, G. Bajaj, L.L. Siu
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile